Steven Cohen Io Biotech, Inc. Transaction History
Point72 Asset Management, L.P.
- $51 Billion
- Q3 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Io Biotech, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 250,000 shares of IOBT stock, worth $205,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250,000Holding current value
$205,000% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding IOBT
# of Institutions
22Shares Held
9.9MCall Options Held
0Put Options Held
0-
Novo Holdings Hellerup, G72.51MShares$2.06 Million0.07% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.53MShares$1.25 Million0.09% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.39MShares$1.14 Million0.0% of portfolio
-
Marshall Wace, LLP London, X01.05MShares$863,1570.0% of portfolio
-
Bank Of America Corp Charlotte, NC800KShares$655,9610.0% of portfolio
About IO Biotech, Inc.
- Ticker IOBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,815,300
- Market Cap $23.6M
- Description
- IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...